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http://www.virologyj.com/content/11/1/7RESEARCH Open AccessCD4+CD25+ T regulatory cells activated during
feline immunodeficiency virus infection convert T
helper cells into functional suppressors through a
membrane-bound TGFβ / GARP-mediated
mechanism
Michelle M Miller1,2†, Christopher S Petty3†, Mary B Tompkins1,2 and Jonathan E Fogle1,2,4*Abstract
Background: We and others have previously reported that cell membrane-bound TGFβ (mTGFβ) on activated T
regulatory (Treg) cells mediates suppressor function. Current findings suggest that a novel protein known as
Glycoprotein A Repetitions Predominant (GARP) anchors mTGFβ to the Treg cell surface and facilitates suppressor
activity. Recently, we have described that GARP+TGFβ+ Treg cells expand during the course of FIV infection. Because
Treg cells are anergic and generally exhibit poor proliferative ability, we asked how Treg homeostasis is maintained
during the course of feline immunodeficiency virus (FIV) infection.
Results: Here, we report that Treg cells from FIV+ cats express GARP and mTGFβ and convert T helper (Th) cells
into phenotypic and functional Treg cells. Th to Treg conversion was abrogated by anti-TGFβ or anti-GARP
treatment of Treg cells or by anti-TGFβRII treatment of Th cells, suggesting that Treg cell recruitment from the Th
pool is mediated by TGFβ/TGFβRII signaling and that cell-surface GARP plays a major role in this process.
Conclusions: These findings suggest Th to Treg conversion may initiate a cascade of events that contributes to the
maintenance of virus reservoirs, progressive Th cell immunosuppression, and the development of immunodeficiency,
all of which are central to the pathogenesis of AIDS lentivirus infections.
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Thymus-derived T regulatory (Treg) cells are a distinct
population of immunosuppressive CD4+ lymphocytes
identified by constitutive expression of CD25 (IL2-R α-
chain), GITR, CTLA-4 and the nuclear transcription
factor, FoxP3 [1-3]. In addition to the well described
Treg cells involved in self-tolerance, a population of
pathogen-induced Treg cells has been described which
express biologically active membrane TGFβ (mTGFβ)
and play a major role in modulating immune responses to* Correspondence: jefogle@ncsu.edu
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stated.a variety of infectious agents by suppressing pathogen-
induced CD4+ and CD8+ effector cells [4-7]. Expression of
mTGFβ on activated Treg cells has recently been shown
to be regulated by the glycoprotein A repetitions predom-
inant (GARP) protein which is specifically expressed in
the lymphoid compartment on regulatory cells and binds
latent TGFβ to the Treg cell membrane [8-13]. Recent evi-
dence has suggested that GARP functions in the conver-
sion of latent TGFβ to biologically active TGFβ by
enabling the cleavage of the latency associated peptide
(LAP) of surface bound TGFβ by integrins (Wang 2012)
[13]. However, it is not clear if this is the solitary mechan-
ism for mTGFβ activation or if additional interactions
occur during GARP:TGFβ association. We recently re-
ported that TGFβ is anchored to the Treg cell surface bytd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
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active and capable of suppressing Th cell function [8].
Although there is considerable knowledge as to how
mTGFβ+ Treg cells mediate suppression, there is less
knowledge of the mechanism(s) that maintain their num-
bers and function in the peripheral immune compartment
and how GARP may be involved. As Treg cells are anergic
and exhibit limited ability to expand, there must be other
factors maintaining their homeostasis [1,2,14,15]. Chen
et al. [16] reported that CD4+CD25- T cells stimulated via
their TCR and treated with soluble TGFβ converted to a
Treg cell phenotype, suggesting a mechanism for Th to
Treg cell conversion. We previously reported that feline
CD4+CD25- Th cells could be converted to a Treg pheno-
type (CD25+mTGFβ+FoxP3+) by treatment with ConA
and soluble TGFβ [17]. These converted cells displayed
immunosuppressive function against ConA-stimulated
CD4+CD25- Th cells, suggesting that they possessed both
the functional and phenotypic characteristics of activated
Treg cells. To provide a mechanism for Th to Treg con-
version, we demonstrated that ConA treatment of CD4
+CD25- Th cells up-regulates expression of TGFβRII on
their surface, rendering them susceptible to Treg cell con-
version by treatment with soluble TGFβ [17]. We also re-
ported that anti-TGFβ receptor II (TGFβRII) treatment of
ConA-stimulated Th cells abrogated the Th to Treg con-
version, supporting a role for TGFβ/TGFβRII signaling in
this conversion process [17]. Recent studies indicate that
peripheral Treg cells, once activated, express both mTGFβ
and GARP on their surface and that both molecules are
instrumental in Treg cell suppressor function [11,12]. It is
not known if this TGFβ/GARP complex plays a role in re-
cruitment of Treg cells from the Th cell pool but evidence
suggests that it may be integral to contact-dependent
TGFβ signaling through TGFβRII [11,12].
The in vivo activation of Treg cells and subsequent
suppression of CD4+ Th cells has been demonstrated in
HIV and feline immunodeficiency virus (FIV) infection and
likely represents an important component of lentiviral-
induced immune suppression [4,5,18-20]. The exact mech-
anism underlying lentivirus-induced Treg cell activation is
still unclear. However, we and others have previously dem-
onstrated that CD4+CD25+ Treg cells are preferentially in-
fected with FIV and activated during FIV infection
[14,21-23]. Further, we have demonstrated that GARP
bound mTGFβ is up-regulated on the activated Treg cell
surface [8]. Many reports suggest that during the course of
lentivirus infection the percentage of CD4+CD25+ cells
among the CD4+ fraction remains stable, particularly in
lymphoid organs, despite the overall decline in CD4+ cell
numbers [4,20,24,25]. Therefore, a mechanism must exist
by which CD4+CD25+ Treg cells are generated to maintain
their homeostasis [1,2,24,26,27]. Several groups have dem-
onstrated the ability of Treg cells to induce suppressoractivity to Th cells, suggesting a mechanism for Treg cell
recruitment and the maintenance of Treg cell homeostasis
[28-30]. Based upon our work and work from others, we
hypothesized that activated TGFβ+GARP+ Treg cells from
FIV+ cats were capable of converting CD4+ Th cells to
Treg cells, thereby maintaining Treg cells numbers and
function during the course of FIV infection. Data pre-
sented herein support this hypothesis by first demonstrat-
ing that TGFβ and GARP are up-regulated on the surface
of CD4+CD25+ Treg cells and TGFβRII is up-regulated on
CD4+ Th cells from FIV-infected cats when compared
to uninfected cats. Further, we show that co-culture of
these two lymphocyte populations results in conversion
of CD4+ Th cells into phenotypic and functionally
immunosuppressive CD4+CD25+mTGFβ+GARP+FoxP3+
Treg cells. This Th to Treg conversion was blocked by
either pretreatment of Treg cells with anti-TGFβ or
anti-GARP antibodies or by pretreatment of target
CD4+ Th cells with anti-TGFβRII antibodies. These results
further support our hypothesis that one of the important
mechanisms for maintaining peripheral Treg cell homeo-
stasis is recruitment from the CD4+ Th cell pool in a
TGFβ/GARP dependent manner. In the case of lentivirus
infection, where both Treg and Th cells are chronically
activated, maintenance of CD4+CD25+ Treg numbers and
function may be favored at the expense of the Th cell pool.
Therefore, chronic, progressive recruitment of immuno-
suppressive Treg cells from the Th cell pool could be an
important factor contributing to both the maintenance of
an activated Treg cell pool and the progressive Th cell
immune deficiency characteristic of lentiviral infection.
Results
Membrane-bound TGFβ (mTGFβ) and GARP on the surface of
CD4+CD25+ Treg cells and TGFβRII expression on CD4+CD25-
Th cells are increased during chronic FIV-infection
We have reported that ConA/TGFβ-stimulated CD4+C
D25- Th cells are converted to immunosuppressive
CD25+mTGFβ+FoxP3+ Treg cells and that this conver-
sion is abrogated by pre-treatment of ConA-stimulated
Th target cells with anti-TGFβRII suggesting a TGFβ-
TGFβRII mediated process [17]. Previously, Vahlenkamp,
et al. [31] reported that CD4+CD25+ Treg cells from
FIV+ cats are constitutively activated in vivo. We asked
if these in vivo activated CD4+CD25+ Treg cells from
FIV+ cats upregulate the activation markers GARP and
mTGFβ. PBMC were isolated from 6 FIV negative cats
and 6 chronically FIV-infected cats and analyzed for sur-
face expression by flow cytometry. As shown in Figure 1,
a significant increase in the percentage of CD4+CD25+ T
cells expressing both GARP and mTGFβ was observed
in FIV-infected cats when compared to FIV negative
control cats (Figure 1A and B). Given that long-term
FIV infection is associated with chronic T cell activation
Figure 1 PBMCs from FIV-infected cats display increased surface expression of TGFβ and GARP on CD4+CD25+ lymphocytes and
TGFβRII on CD4+CD25- lymphocytes. PBMCs from FIV-infected or control cats were analyzed for surface expression of CD4, CD25, TGFβ, GARP
and TGFβRII by flow cytometry. Cells were gated on CD4+CD25+ or CD4+CD25- populations and analyzed for percent expression of A. TGFβ, B.
GARP or C. TGFβRII. Box-whisker plots represent the 5th and 95th percentiles (whisker), 25th and 75th percentiles (box), and median of percent
CD4+CD25+ and CD4+CD25- expression from 6 FIV-positive and 6 FIV-negative cats. Symbols represent individual cats. CD4+CD25+ cells from
FIV+ cats exhibit greater surface expression of TGFβ and GARP when compared to CD4+CD25+ cells from FIV- cats. CD4+CD25- cells from FIV+ cats
exhibit greater surface expression of TGFβRII than CD4+CD25- cells from FIV- cats. (p <0.05, Mann–Whitney test for significance).
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pothesized that mTGFβ on activated Treg cells mediates
suppressor function against Th cells expressing TGFβRII
[31-33]. To address this question, we analyzed the ex-
pression of TGFβ-RII on the surface of CD4+CD25- cells
from FIV+ cats. As shown in Figure 1C, there is a signifi-
cant increase in the percentage of CD4+CD25- T cells
from FIV+ cats expressing TGF-βRII when compared to
control cats.
CD4+CD25+ Treg cells from FIV+ cats convert CD4+CD25-
Th cells to a Treg phenotype
Chen et al. [16] demonstrated that soluble TGFβ treat-
ment coupled with TCR co-stimulation of Th cellsinduces a Treg phenotype and suppressor function. We
also reported a similar in vitro Th to Treg conversion of
feline ConA-stimulated CD4+CD25- treated with soluble
TGFβ [17]. There are a handful of reports describing
the ability of Treg cells to induce suppressor activity in
Th cells [28-30]. Increased expression of TGFβ on Treg
cells and TGFβRII on Th cells could promote interaction
between these two T cell subsets and facilitate the con-
version of Th cells to Treg cells. To test this, freshly
isolated, constitutively active CD4+CD25+ Treg cells
from FIV+ cats were membrane-labeled with Vybrant
DiD then co-cultured with ConA-activated, non-labeled
CD4+CD25- Th target cells as illustrated in Figure 2.
After 5 days of co-culture, the DiD positive cells were
Figure 2 Experimental design for CD4+CD25+ Treg cell-mediated conversion of feline CD4+CD25- T cells to iTreg cells. Single-cell
suspensions were prepared from PLNs collected from FIV-infected or uninfected control cats. Cells were stained with anti-feline CD25 FITC and
anti-feline CD4 PerCP labeled antibodies and CD4+CD25+ T cell populations purified by FACS. Converter CD4+CD25+ cells from control cats were
stimulated with LPS/IL2 for 4 days, whereas CD4+CD25+ cells from FIV-infected cats are constitutively active and therefore were not stimulated
prior to co-culture. PLN cells from FIV negative cats were FACs purified into CD4+CD25- Th target cells or CD4-CD8- APCs and stimulated for 4
hours with ConA. Converter cells were labeled with Vybrant DiD membrane dye and co-cultured with the purified CD4+CD25- Th cells at a
converter to target cell ratio of 1:2 in medium supplemented with 100 U/mL IL2. After 5 days, DiD membrane negative cells were FACS purified
from the co-culture and analyzed for phenotype and function. In some experiments, anti-TGFβ, anti-GARP, or anti- TGFβRII antibodies were added
prior to the conversion assay or prior to the functional assay.
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function of the remaining cells, referred to herein as in-
duced Treg (iTreg) cells, were analyzed. The positive
control for conversion consisted of CD4+CD25- cells
from FIV negative cats cultured with ConA and soluble
TGFβ which induces FoxP3 expression and the acquisi-
tion of suppressor function in feline Th cells as de-
scribed previously [17]. Negative controls consisted of
CD4+CD25- cells cultured in medium alone or in
medium supplemented with either 5 ug/mL ConA or
100 U/mL IL2.
Following culture of CD4+CD25+ PLN cells from FIV-
infected cats with CD4+CD25- cells from FIV negative
cats, the latter population (iTreg cells) was analyzed by
flow cytometry for the expression of CD25, GARP,
TGFβ, TGFβRII and FoxP3. Figure 3A shows representa-
tive dot plots from one conversion assay and Figure 3B
shows the averages of 3 experiments. Non-stimulated
CD4+CD25- Th cells do not express the Treg-associated
surface proteins CD25, GARP, or TGFβ and less than10% of these cells express TGFβRII, consistent with a
resting Th population. Treatment of Th cells with ConA
or IL2 alone resulted in an increased percentage of cells
expressing CD25 and TGFβRII, suggesting Th cell acti-
vation, but there was no increase in cells expressing the
Treg cell markers GARP, mTGFβ or FoxP3 (Figure 3A-B).
Only culturing in the presence of ConA and TGFβ, as we
have previously demonstrated, or culturing with activated
Treg cells from FIV+ cats resulted in the expression of
GARP, mTGFβ, and FoxP3, as well as CD25 and TGFβRII,
on approximately one third of the Th cells. As the stable
expression of forkhead transcription factor FoxP3 is the
defining marker of CD4+CD25+ Treg cells and is required
for both homeostasis and suppressor function, we also an-
alyzed FoxP3 mRNA expression in Th cells converted to
iTreg cells [3]. Similar to the flow cytometry analysis, only
Th cells cultured in the presence of ConA and TGFβ or
with activated Treg cells from FIV+ cats led to the expres-
sion of FoxP3 or GARP mRNA (Figure 3C and D). This
phenotype (CD25+GARP+mTGFβ+FoxP3+) is consistent
Figure 3 (See legend on next page.)
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Figure 3 CD4+CD25+ Treg cells from FIV-infected cats are capable of converting CD4+CD25- Th cells from FIV-negative cats into
phenotypic iTreg cells. A. Untreated CD4+CD25- T cells, soluble TGFβ and ConA treated CD4+CD25- cells, or CD4+CD25- cells from control cats
co-cultured with Treg cells from FIV+ cats were analyzed by flow cytometry for the Treg surface phenotypic markers CD25, GARP, TGFβ and
TGFβRII after the 5 days in culture. Representative dot plots are shown. The percent of cells expressing each marker is at the top right of each dot
plot. B. CD4+CD25- cells treated as described for (A), as well as CD4+CD25- cells treated with IL2 alone or ConA alone were analyzed for
expression of CD25, GARP, TGFβ, TGFβRII and FoxP3. Bars represent the mean ± SEM percent of cells expressing each marker from three
independent experiments from separate cats. C and D. Target CD4+CD25- cells from two FIV+ cats were cultured as described above then
analyzed for FoxP3 (C) or GARP (D) mRNA expression by PCR. Lanes 1: freshly isolated CD4+CD25+ Treg cells from Cat A. Lanes 2 and 3:
CD4+CD25- cells from Cat A (2) or Cat B (3) cultured for 5 days with IL2 alone. Lanes 4 and 5: CD4+CD25- cells from Cat A (4) and Cat B (5)
cultured for 5 days with soluble TGFβ (10 ng/mL) and ConA (5 ug/mL). Lanes 6 and 7: ConA-activated CD4+CD25- cells from Cat A (6) and Cat B
(7) co-cultured for 5 days with autologous CD4+CD25+ then purified by FACS. The target cells cultured with sTGFβ/ConA or with activated Treg
cells express FoxP3 and GARP mRNA.
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capable of converting Th cells to a Treg phenotype.
CD4+CD25+ T cells from FIV-infected cats convert
CD4+CD25- Th cells into iTreg cells capable of suppressing
Th cell IL2 production and proliferation
Figure 3 demonstrates that Th cells can be induced to
express surface and intracellular markers consistent with
a Treg cell phenotype. Therefore, we asked if these
converted Th cells were truly functional suppressor
cells. ConA-stimulated CD4+CD25- target cells were
co-cultured with iTreg effector cells at a 1:2 effector to
target ratio (iTreg to CD4+ Th) for 24 hours, then cul-
ture supernatant was collected and analyzed for IL2 by
ELISA. As shown in Figure 4A, addition of iTreg cells
to CD4+ Th cultures from FIV+ cats (fifth column) re-
sulted in a significant reduction of IL2 in the culture
supernatant which was similar to that of Treg cells directly
isolated from FIV+ cats (fourth column). As shown in
Figure 4A, addition of unconverted CD4+CD25- cells to
the CD4+ Th culture resulted in a slight enhancement
of IL2 in the culture supernatant. iTreg suppressor
function was also assayed by a standard proliferation
assay of ConA-activated CD4+CD25- target Th cells.
The suppressor function of the converted iTreg cells
was similar to suppression by isolated CD4+CD25+ Treg
cells from FIV+ cats (Figure 4B, open squares, closed
squares). In addition, pre-treatment of iTreg cells with
anti-TGFβ effectively eliminated the ability of iTreg cells
to inhibit the proliferation of activated CD4+CD25- T cells
(Figure 4C). These results demonstrate that in addition to
displaying the phenotypic characteristics of a regulatory T
cell population, the iTreg cells produced from co-culture
of Th cells with Treg cells from FIV+ cats have functional
characteristics of Treg cells.
We have demonstrated previously that IL2 and LPS
treatment is required to activate CD4+CD25+ Treg cells
from FIV- cats [8,31]. To confirm that conversion of
CD4+CD25- cells into iTreg cells was due to activated
Treg cells and not an artifact of co-culture conditions
(IL2, LPS, ConA) or an indirect effect of FIV infection,Th cells were co-cultured with DiD stained CD4+CD25+
cells from FIV negative control cats treated prior to
co-culture with IL2/LPS. After the 5 day co-culture,
the DiD “converter” population was depleted and the
remaining cells were assayed for effector function using
the [H3]-Thymidine assay for proliferation of activated
Th target cells. Like constitutively activated Treg cells
from FIV+ cats, in vitro activated CD4+CD25+ cells from
FIV- cats converted Th cells into functional iTreg cells
as measured by inhibition of proliferation of ConA stim-
ulated Th target cells (Figure 4D, open squares) but were
not quite as efficient at suppression as directly isolated
CD4+CD25+ Treg cells (Figure 4D, closed squares, posi-
tive control). Conversion did not appear to be an artifact
of co-culture as CD4+CD25+ cells treated with IL2 alone
were not capable of inducing iTreg function in Th target
cells (iTreg conversion control, not shown). Likewise,
CD4+CD25- cells treated with IL2/LPS (triangles, Th
suppression assay control), or IL2 alone (not shown) did
not exhibit inhibition of Th target cell proliferation.
Blockade of TGFβ/TGFRII Interaction Abrogates CD4+
CD25+ Treg-Induced Conversion of CD4+CD25- Th cells to
iTreg cells
To confirm that CD4+CD25+ Treg cells mediate conver-
sion of CD4+CD25- Th to iTreg cells by a TGFβ/TGFβRII
signaling pathway, DiD labeled CD4+CD25+ Treg cells
from FIV-infected cats were pre-treated with anti-TGFβ
or anti-GARP, or ConA activated CD4+CD25- Th target
cells were pre-treated with anti-TGF-RII antibodies prior
to co-culture. Flow cytometric analysis demonstrated
that pretreatment of CD4+CD25+ cells with anti-TGFβ
(Figure 5A) or anti-GARP (Figure 5B) or pre-treatment of
CD4+CD25- cells with anti-TGFβRII (Figure 5C) for 15
minutes prior to flow cytometry analysis prevented the
binding of fluorochrome-labeled detection antibodies,
demonstrating efficient blocking of these surface proteins.
After blocking TGFβ or GARP on DiD-labeled CD4+CD25+
cells or TGFβRII on CD4+CD25- cells, cells were co-
cultured then DiD+ cells depleted, as described for in vitro
conversion previously. The remaining cells were analyzed
Figure 4 Activated feline CD4+CD25+ T cells from FIV-infected
cats convert CD4+CD25- Th cells into functional iTreg cells. CD4
+CD25- cells were converted by co-culture with CD4+CD25+ T cells
(outlined in Figure 2) and effector function analyzed. For suppression
assays, CD4+CD25- (Th) and CD4-CD8- (APCs) from control cats were
combined at a 1:1 ratio for use as targets and, where indicated, stimu-
lated for 1 hour with ConA (5 ug/uL). A. Nonstimulated CD4+CD25-
(negative control), LPS/IL2 activated CD4+CD25+ (positive control),
or iTregs from conversion co-cultures with FIV+ Tregs were used as
effectors. After 24 hours, IL2 was analyzed in the supernatent by
ELISA in triplicate. Data shown is representative of two experi-
ments. Error bars represent the SEM (*p < .05 Mann–Whitney). B.
CD4+CD25- target cells were co-cultured with iTregs (open square),
or freshly isolated CD4+CD25+ cells from an FIV+ cat (closed
square), or CD4+CD25- cells (inverted triangle) at various E:T ratios
for 72 hrs and pulsed with 3H-thymidine. Symbols are the mean ± SEM
percent inhibition of proliferation of targets from three experiments. C.
iTregs either untreated or pre-incubated with anti-TGFβ were used as
effectors in a proliferation assay as described in B. Bars represent the
mean ± SEM percent inhibition of proliferation of Th targets for three
experiments. D. CD4+CD25- targets for the iTreg conversion assay
were first cultured for 5 days with DiD-labeled CD4+CD25+ Tregs iso-
lated from an FIV negative cat and activated by 5 day IL2/LPS treat-
ment. Following co-culture, converted cells were isolated by FACS and
used as effectors in a standard 72 hour 3H-thymidine proliferation assay
with CD4+CD25- targets at various E:T ratios. Effector cell control for the
assay was 5 day IL2/LPS activated CD4+CD25+ Tregs (closed square,
positive control). Bars represent the mean ± SEM percent inhibition of
proliferation of targets and represent three separate experiments.
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cells. Flow cytometry analysis revealed that anti-TGFβ or
anti-GARP pre-treatment of CD4+CD25+ T cells, and/or
anti-TGFβRII pre-treatment of CD4+CD25- cells prior to
co-culture significantly reduced the expression of TGFβ
and GARP on the surface of the CD4+ Th cells after co-
culture, suggesting failure to convert Th cells to iTreg cells
(Figure 5D). In addition, anti-TGFβ or anti-GARP treatment
of Treg cells, or anti-TGFβRII treatment of Th cells pre-
vented the expression of FoxP3 mRNA in the Th target
population (Figure 5E), suggesting that mTGFβ and GARP
on Treg cells and TGFβRII on Th cells are crucial for the
Treg-mediated conversion of CD4+CD25- Th cells to an
iTreg phenotype.
Blocking mTGFβ on Treg converter cells (Figure 5D,
bar 4) or blocking TGFβRII on Th target cells (Figure 5D,
bar 5) before co-culture abrogated the induction of sup-
pressor positive iTreg cells as measured by proliferation
(Figure 5 F) and IL2 production (Figure 5G, bars 4 and 5)
by CD4+ Th cells. Blocking of TGFβ on converter cells
in conjunction with anti-TGFβRII on activated Th target
cells completely inhibited the induction of functional
iTreg cells (Figure 5G, bar 6). Blocking of GARP alone on
converter cells prior to co-culture also completely elimi-
nated the induction of functional iTreg cells (Figure 5G,
bar 7). Thus, the conversion of Th cells to phenotypic and
functional iTreg cells is dependent upon GARP-bound
TGFβ and TGFβRII signaling.
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It is well established that pathogen-induced Treg cells
play a central role in maintaining the balance between
immunity and immunopathology to infectious agents in
the peripheral immune compartment [1,4,5]. However,
mechanisms regulating their homeostasis and suppressor
function remain unclear. This is particularly important
in the case of AIDS lentivirus infection, as Treg cells are
chronically activated and in many cases their numbers
seem to be maintained, even in the face of declining
total CD4+ T cell numbers [4,20,24,25]. These observa-
tions suggest there is a mechanism(s) for maintaining
Treg cell peripheral homeostasis and suppressor func-
tion, as they do not produce IL2, are anergic, and ex-
pand only under specific conditions [15,31]. While a
number of mechanisms have been proposed to explain
Treg cell homeostasis, evidence supports recruitment of
de novo suppressor cells from the Th cell pool [28-30].
As it has been established that Treg cells are chronic-
ally activated and constitutively immunosuppressive
throughout the course of FIV and HIV infections, we
examined the possibility that these activated Treg cells
in FIV-infected cats are capable of converting CD4+ Th
cells into a Treg phenotype (iTreg cells), thereby maintain-
ing population numbers [34,35]. This is hypothesis sup-
ported by the observations that Treg cell homeostasis can
be maintained in the periphery during responses to patho-
gens such as hepatitis viruses, add a comma after viruses
SIV, HIV, and FIV and molecules such as LPS and IL2
have been shown to induce Treg proliferation [31,35].
Chen et al. [16] reported that CD4+CD25- Th cells could
be converted into FoxP3+ immunosuppressive Treg cells
in vitro by stimulation with soluble TGFβ in combination
with TCR engagement, suggesting a role for TGFβ. These
findings are supported by other reports that soluble TGFβ
of activated TGFβRII+ Th target cells in mice induces
suppressor activity [36,37]. Our laboratory has also
demonstrated that stimulation of CD4+CD25- Th cells
with a combination of ConA and TGFβ converted these
cells into CD25+mTGFβ+FoxP3+ functional suppressor
cells [17]. Taken together, these studies indicate that Treg
peripheral homeostasis may be maintained by recruit-
ment from the CD4+CD25- Th cell population in a
TGFβ-dependent process.
In support of Th to Treg conversion in vivo, we dem-
onstrated that, in contrast to Treg cells from uninfected
cats, a significant number of Treg cells in FIV+ cats are
mTGFβ positive and that a fraction of Th cells express
TGFβRII. To examine the concept that in vivo Th to
Treg conversion could occur in the peripheral lymphoid
tissue of FIV+ cats by engagement of TGFβ on Treg
cells with TGFβRII on CD4+ Th target cells, an ex vivo
model for conversion was designed. ConA-activated
TGFβRII+CD4+CD25- Th cells from control cats co-cultured with CD4+CD25+ Treg cells from FIV+ cats dis-
played the Treg-cell markers CD25 and mTGFβ and
expressed immunosuppressor function (iTreg cells), con-
sistent with a Treg cell phenotype. As others have re-
ported that TGFβ regulates the expression of FoxP3 in
Treg cells and as FoxP3 is required for Treg homeostasis
and suppressor function we analyzed iTreg cells for
FoxP3 expression [38-40]. The iTreg cells induced by
co-culture with autologous Treg cells markedly up-
regulated FoxP3 mRNA. We also examined surface
GARP expression on the iTreg cells, as GARP has been
reported to be unique to Treg cells and important for
mTGFβ function by anchoring TGFβ to the cell surface
[8-13]. We also previously reported that GARP is
expressed in association with mTGFβ on activated Treg
cells from FIV+ cats [8]. The results reported here dem-
onstrate that constitutively activated Treg cells from
FIV+ cats induced GARP mRNA and protein expression
in Th cell targets following co-culture confirming that
iTreg cells have an activated Treg phenotype. Although
the observed Treg cell virus load during chronic infec-
tion is typically low, Treg cells are highly susceptible to
FIV infection in vitro and a percentage of the cells iso-
lated from FIV-infected cats for the conversion assays
may have carried FIV, raising the question of whether
Th conversion in these cocultures was a result of de
novo infection in the target cells. However, given the
slow rate of growth inherent to lentiviruses only a very
small fraction of T cells would become newly infected
during a 5 day coculture. Therefore, while this may still
contribute to some of the activation and conversion ob-
served, it would not account for the nearly 50% conver-
sion rate demonstrated by the phenotypic analysis
reported in Figure 3.
As shown in Figure 4, iTreg cells are functionally acti-
vated, as they are capable of suppressing IL2 production
and proliferation by activated CD4+CD25- Th cells in vitro
at a level comparable to that of constitutively activated
Treg cells from FIV+ cats. Additionally, these iTreg cells
suppress activated Th cell proliferation by the same
TGFβ-mediated mechanism as non-induced Treg cells.
In this regard, we and others have demonstrated that
blocking of TGFβ on activated Treg cells or blocking of
TGFβ-RII on Th target cells abrogates Treg suppressor
function, suggesting that Treg suppression is mediated by
a TFGβ/TGFβRII signaling pathway [8,17,36]. In this
study, addition of anti-TGFβ or anti- TGFβRII antibody
to the suppressor assay for iTreg cells inhibited the sup-
pressor function of these cells, supporting the role of
TGFβ/TGFβRII in mediating suppression. The size of the
Treg cell compartment, FoxP3 expression, and suppressor
function in CD4+ T cells have been shown to be de-
pendent on signals induced by TGFβ in the periphery
[39]. In concert with these findings, the data presented in
Figure 5 (See legend on next page.)
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Figure 5 Feline CD4+CD25+ T cell-mediated iTreg conversion occurs by a TGFβ/TGFβRII dependent mechanism. A-C. To confirm blocking
of TGFβ (A) or GARP (B) on CD4+CD25+ Treg cells and TGFβRII (C) on CD4+CD25- Th cells, cells were pretreated with unconjugated specific or
isotype control antibody, then analyzed by flow cytometry using conjugated antibody to confirm blocking of TGFβ and GARP on CD4+CD25+
and TGFβRII on CD4+CD25- cells. Data represent three experiments. D-G. ConA-activated Th targets were pre-treated with anti-TGFβRII antibodies
and/or Tregs were pre-treated with anti-TGFβ or anti-GARP antibodies for 30 min, washed, co-cultured for 5 days, then target cells were analyzed
for induction of Treg phenotype and function. D. Dot plots demonstrating surface TGFβ expression following conversion of Th cells to iTregs and
blocking TGFβ/TGFβRII or GARP prior to co-culture (upper panels). Surface expression of both (1) GARP and TGFβ were decreased by blocking (2)
TGFβ, (3) TGFβRII, (4) TGFβ/TGFβRII, or (5) GARP (lower panel). Data represents one blocking study. E. Treatment of CD4+CD25+ converter cells
with anti-TGFβ (lane 1) or anti-GARP (lane 2) or of CD4+CD25- target cells with anti-TGFβRII (lane 3) prior to co-culture prevented induction of
FoxP3 in Th targets. Lane 4: Th targets with no antibody blockade. F, G. Suppressor function of iTregs was evaluated by 3H-thymidine proliferation
(F) or by IL2 suppression assay (G). Suppressor function of iTregs was reduced by anti-TGFβ treatment of converter Treg cells (F black bar, G lane
4) or by anti-TGFβRII treatment of target Th cells (F pattern bar, G lane 5) prior to conversion. Conversion was completely abrogated when TGFβ
and TGFβRII were blocked simultaneously or when GARP was blocked during conversion (G lanes 6 and 7). Data in F represents mean + SEM of
three experiments; G mean ± SEM of experimental triplicates.
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Treg with TGFβRII on Th cells converts the latter into
iTreg cells in FIV+ cats. Importantly, conversion of Th
cells was also observed following coculture with activated
Treg cells from noninfected cats as shown in Figure 4D.
This experiment demonstrates that the conversion of
iTreg cells in these coculture conditions is not an artifact
of infection status or chronic FIV antigen presentation
and suggests that Treg cells are converting Th cells
by a more direct interaction such as mTGFβ signaling.
The role of the TGFβ/TGFβRII signaling pathway in the
conversion of Th to iTreg cells was confirmed by the ob-
servation that pretreatment of activated Treg cells with
antibodies to TGFβ or GARP or pretreatment of activated
Th cells with anti-TGFβRII blocked the conversion of Th
cells to an iTreg phenotype. Dieckmann et al. [28] reported
that activated CD4+CD25+ Treg cells are capable of sup-
pressing both CD4+ and CD8+ T cells but induce a Treg
phenotype only in activated Th cells and not in CD8+ T
cells. Similar to those findings, we also have demonstrated
that constitutively activated Treg cells from FIV+ cats sup-
press both CD4+ Th and CD8+ T cell responses, but do not
induce CD8+ T cell suppressor function [18,20,28]. The
results of the studies reported here clearly demonstrate
that activated Tregs induce suppressor function in CD4+
Th cells. To our knowledge, this is the first report describ-
ing Th to iTreg cell conversion by lentivirus-activated Treg
cells.
Conclusions
Collectively, these data demonstrate that peripheral Treg
homeostasis may be regulated by recruitment from the
Th cell pool by mTGFβ/TGFβ-RII signaling. We believe
lentivirus infection may promote this process and dis-
rupt the normal balance between Th and Treg cells by
chronic activation of both Treg and Th cells, tipping the
equilibrium in favor of iTreg cells at the expense of the Th
cell pool. Thus Th to iTreg cell conversion that is mediated
by activated CD4+CD25+ mTGFβ+FoxP3+ Treg cells maylimit expansion and effector function of anti-viral CD4+ T
cells by converting them to CD25+mTGFβ+FoxP3+ iTreg
cells, contributing to the Treg cell pool during the progres-
sion of AIDS lentivirus infections. This is an important
concept, as the relative balance between CD4+ Th cell im-
mune responses and CD4+CD25+ Treg immune suppres-
sion during the acute stage of virus infection may help to
determine the ultimate virus set point and the long-term
ability to control viremia, and in effect predict disease
progression. A more in depth understanding of conversion
events and the emergence of iTreg populations during
acute infection are instrumental in understanding this
process. The data presented in this manuscript clearly
demonstrates that FIV-AIDS lentivirus infection is capable
of activating CD4+CD25+ Treg cells expressing mTGFβ
that are, in turn, capable of interacting with TGFβRII+
CD4+ Th cells and converting the Th cells into iTreg cells
in vitro. These studies help explain both the maintenance
of Treg numbers and function, and provide a possible
mechanism for lentivirus-induced CD4+ T cell immune
dysfunction. We are currently examining how this may
occur in vivo during the course of FIV infection. While
our data clearly demonstrate that GARP is involved in
this conversion, the exact role of membrane associated
GARP in functional activation of mTGFβ on Treg cells
and iTreg cells remains to be determined. A recent report
has suggested that GARP enables the activation of
mTGFβ by providing a scaffold on the Treg cell sur-
face, positioning the latent TGF molecule in such a
way as to facilitate its interaction with integrins which
cleave the latency associated peptide (LAP), producing
biologically active mTGFβ (Wang 2012). The possi-
bility remains that additional interactions, either at
the Treg cell surface or during intracellular protein
transport, are critical for this activation process. The
full characterization and mapping of the mTGFβ acti-
vation process would be invaluable for designing
future Treg studies and should be taken under careful
consideration.
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Cats and FIV infection
Specific pathogen-free cats were obtained from Liberty
Labs (Liberty Corners, NJ) or Cedar River Laboratory
(Mason City, IA) and housed at the Laboratory Animal
Resource Facility at the College of Veterinary Medicine,
North Carolina State University. Cats were inoculated
with the NCSU1 isolate of FIV, a pathogenic clade A
virus, as described by Bucci et al. [41]. FIV-infection was
confirmed by immunoblot analysis and provirus detec-
tion by PCR using primers specific for the FIV-p24 GAG
sequence. At the time samples were taken, cats had been
infected with FIV for at least 5 years and were clinically
asymptomatic. Non-infected control cats ranged in age
from 3 to 6 years and were housed separately from
FIV-infected cats. Protocols were approved by the North
Carolina State University Institutional Animal Care and
Use Committee.
Sample collection and preparation
Whole blood (28 ml/cat) was collected by jugular
venipuncture into EDTA Vacutainer tubes (Becton-
Dickinson, Franklin Lakes, NJ). PBMC were isolated by
Percoll density gradient centrifugation (Sigma-Aldrich,
St. Louis, MO) as previously described [42] or by Ficoll-
Histopaque-1077 density gradient centrifugation (Sigma-
Aldrich, St-Louis, MO) following the manufacturer’s
guidelines. Single-cell suspensions were prepared from
popliteal or submandibular peripheral lymph nodes
(PLN) obtained through surgical biopsies by gently and
repeatedly injecting sterile PBS into the tissue using an
18G needle until the cells were released from the tissue.
Cell counts and viability were determined by trypan blue
dye exclusion and viability was always >90%.
Reagents and antibodies
Recombinant human IL2 was obtained through the AIDS
Research and Reference Reagent Program, Division of
AIDS, NIAID, NIH from Dr. Maurice Gately, Hoffmann -
La Roche Inc. LPS and Concanavalin A (ConA) were pur-
chased from Sigma-Aldrich (St. Louis, MO). Anti-mouse
IgG coated magnetic Dynabeads® M-450 were purchased
from Dynal (Great Neck, NY). Streptavidin–PerCP was
purchased from BD Biosciences PharMingen (San Diego,
CA). Anti-TGFβ1 (MAB240) was purchased from R&D
Systems (Minneapolis, MN) and conjugated to allophy-
cocyanin (APC) or left unconjugated for blocking studies;
PE-conjugated anti-TGFβ-RII (FAB241P), neutralizing
anti-TGFβRII (AF-241-NA), and recombinant human
TGFβ1 (240-B) were also purchased from R&D Systems.
Mouse anti-feline CD25 (mAb 9 F23) was kindly provided
by K. Ohno (University of Tokyo, Tokyo, Japan). Anti-
CD21 was purchased from Serotec (Raleigh, NC). Mouse
anti-feline CD4 (mAb 30A) and CD8 (mAb 3.357) weredeveloped in our laboratory [43]. PE conjugated rat
anti-mouse FoxP3 (FJK-16 s) was purchased from eBiosci-
ence (San Diego, CA). FITC-conjugated anti-GARP IgG2b
monoclonal antibody (LRRC32, Plato-1) was purchased
from Enzo life Sciences (Ann Arbor, MI).
Flow cytometric analysis
For comparison of TGFβ and TGFβRII in chronic FIV-
infected or uninfected cats, at least 5 × 105 PBMC were
stained for surface expression using specific antibodies
and three-color flow cytometry was performed on a
FACSCaliber flow cytometer (BD Biosciences, Mountain
View, CA). Lymphocytes were gated based on forward
vs. side scatter, and 20,000 gated events were acquired
and stored list-mode fashion for analysis using CellQuest
software. For phenotyping studies, sorted and/or cul-
tured cells were stained for surface expression of CD4,
CD25, TGFβ, GARP and TGFβRII. For intracellular
staining of FoxP3, cells were first stained for CD4 and
CD25 expression, washed in PBS, incubated with 4%
PFA for 10 minutes, and washed twice more. Cells were
then incubated in 0.1% Triton x-100 for 30 minutes,
washed with PBS + 4% FBS, resuspended in 100 uL of
PBS and incubated with FoxP3-specific antibody at room
temperature for 20 minutes. Cells were washed in PBS +
4% FBS and analyzed on the FACSCalibur flow cyt-
ometer, lymphocytes were gates on forward vs. side scat-
ter and 20,000 gated events were acquired and stored
list-mode fashion for analysis using CellQuest software.
All gating was determined by isotype controls.
Purification of lymphocyte populations
CD4+CD25+ and CD4+CD25- cell populations were puri-
fied as previously described [17,20]. Briefly, for FACS
purification, PBMCs or LN cells were stained with anti-
CD4, anti-CD25 and anti-CD8. CD4+CD25+, CD4+CD25-
and CD4-CD8- (used as antigen presenting cells [APCs])
cell subsets were purified using a high-speed, high-purity
fluorescence activated cell sorter (MoFlo, DakoCytoma-
tion). The purity of FACS sorted cell populations was al-
ways > 95%. CD4+CD25- T cells for use as target cells in
proliferation assays were enriched using biomagnetic bead
separation using goat anti-mouse IgG-coated beads as de-
scribed by Bucci et al. [41]. Briefly, CD21+ B cells, CD8+,
and CD25+ T cells were depleted in successive steps using
magnetic beads coated with anti-CD21, anti-CD8 and
anti-CD25 antibody respectively. Purity of the magnetic
bead enriched CD4+CD25- T cells was > 90%, as verified
by flow cytometric analysis.
Treg cell-induced conversion assay
Converter cells consisted of purified CD4+CD25+ T cells
from either control cat or FIV-infected cat PLN. In the
case of control cats, the converter cells were activated by
Miller et al. Virology Journal 2014, 11:7 Page 12 of 14
http://www.virologyj.com/content/11/1/7culturing (4 × 106 per well, 24-well plate) for 4 days in the
presence of LPS (10 μg/mL) plus IL2 (100 U/mL) then
washed twice and labeled with Vybrant DiD (Molecular
Probes) fluorescent dye. In the case of FIV-infected cats,
as the CD4+CD25+ T cells are constitutively activated, the
converter cells were freshly isolated and labeled with Vi-
brant DiD (see Figure 2). Converter cell control groups
consisted of CD4+CD25- or CD4+CD25+ cells from con-
trol cats incubated in IL2 (100 U/ml) alone for 4 days then
labeled with DiD. The positive control for conversion of
CD4+CD25- Th was a 5d treatment of sorted cells with
5 μg/mL ConA and 10 ng/mL soluble TGFβ which has
been described in previous conversion experiments [17].
The target cells for testing conversion cell immunosup-
pressive function consisted of autologous unlabeled CD4
+CD25- T cells freshly purified from peripheral blood and
stimulated with 5 μg/mL ConA and 100 U/ml IL2 for 4 h.
The target cells were washed and added to the converter
cell cultures at a converter to target cell ratio of 1:2. Cul-
tures were kept at 37°C for 5 days in RPMI 1640 supple-
mented with 10% heat-inactivated FBS, 50 μM 2-ME,
1 mM sodium pyruvate, 2 mM L-glutamine, 100 U/ml
penicillin, 100 mg/ml streptomycin, and 10U/ml IL2. After
5 days, DiD positive cells were FACS depleted and the
remaining cells were used in suppression assays, cell sur-
face molecule analysis, and mRNA analysis. The purity of
DiD-depleted cells was >98% as verified by flow cytomet-
ric analysis. For conversion blocking experiments, 100
μg/ml anti–TGFβ or 100 μg/ml anti-GARP was added to
the converter cell population, or 100 μg/ml anti–
TGFβ−RII was added to the target cell population just
prior to co-culture. Experimental design is outlined in
Figure 2.In vitro T cell IL2 suppression assay
Peripheral lymph node (PLN) cells from FIV-negative
cats were FACS purified into CD4+CD25- target cells
and CD4-CD8- APCs, combined at a 1:1 ratio, stimu-
lated for 4 h with 5 μg/ml ConA, washed twice in RPMI
1640, and plated at 2 × 106 cells/mL in 12-well plates.
DiD negative cells from the conversion assays described
above were added as suppressor cells at a suppressor to
target cell ratio of 1:2. Effector cell controls for the
suppressor assay consisted of CD4+CD25+ cells from
control cats that had been stimulated for 4 days with
10 μg/ml LPS and 100 U/ml rhIL2 (positive control)
or non-stimulated CD4+CD25- cells from control cats
(negative control) as suppressor cells. Controls for IL2
production consisted of ConA stimulated CD4+CD25-
cells plus APCs without effector cells (positive control)
and non-stimulated CD4+CD25- cells plus APCs without
effector cells (negative control). After 24 hours, 100 uL
of the supernatant from each well was analyzed intriplicate by IL2 ELISA using the Feline IL2 DuoSet
(DY1890 R&D Systems, Minneapolis, MN) as per man-
ufacturer’s protocol.
In vitro T cell proliferation suppression assay
Enriched CD4+CD25- target cells (106 cells/ml) were
stimulated for 4 h with 5 μg/ml Con A, washed twice in
RPMI 1640, and plated at 5 × 104 viable cells/well in 96-
well U bottom plates. DiD negative cells from the con-
version assays described above were added as suppressor
cells at suppressor to target cell ratios ranging from
0.125:1 to 1:1. Controls for the suppressor assay con-
sisted of CD4+CD25+ cells from control cats that had
been stimulated for 4 days with 10 μg/ml LPS and 100
U/ml rhIL2 (positive control) or non-stimulated CD4+CD25-
cells from control cats (negative control) as suppressor cells.
Effector and target cells were co-cultured at 37°C for 72 hrs,
pulsed with 1 μCi of [3H]TdR/well for the last 18 h and har-
vested using a Filtermate Harvester (Packard Bioscience,
Meriden, CT). [3H]thymidine incorporation was measured
using a Top Count NXT Microplate scintillation counter
(Packard Bioscience). Percent inhibition of proliferation
was determined based on proliferation of CD4+CD25-




= CD4þCD25−aloneð Þ cpm
i
x100
For suppressor activity blocking experiments, the sup-
pressor cells were pretreated with 100 μg/ml anti-TGFβ
for 30 minutes then washed, counted, and added to the
target cells. Assays were run in triplicate.
Reverse transcription PCR analysis of FoxP3 and GARP
FoxP3 mRNA was detected by RT-PCR using feline spe-
cific primers for FoxP3 or GARP as described previously
(Miller et al., 2013, Petty et al., 2008). GAPDH mRNA
expression was used as a normalizing control. Briefly,
total RNA was isolated from 1 × 106 CD4+CD25+ or
CD4+CD25- T cells using RNeasy Protect Mini Kit
(Qiagen, Valencia, CA). Reverse transcription was car-
ried out using a reverse transcription system kit from
Promega as per the manufacturer’s protocol, followed
by PCR using HotStar Taq polymerase (Qiagen, Valencia
CA). PCR products were resolved on agarose/ethidium
bromide gels and visualized using GelRed (Biotium,
Hayward CA).
Statistical analysis
The Mann–Whitney U test (t test for nonparametric data)
was used for pair-wise comparison of parameters. Differ-
ences were considered to be significant at p < 0.05.
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